Advanced Endometrial Carcinoma: Clinical Trials

3 trials for Advanced Endometrial Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 1, Not yet recruiting 1, Recruiting 1

Follow Advanced Endometrial Carcinoma: new trials by email Literature Review of Advanced Endometrial Carcinoma trials Research Report on Advanced Endometrial Carcinoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Biospecimen Collection, Computed Tomography, Elacestrant - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Not yet recruitingJonsson Comprehensive Cancer Center502026-12-182026-06-09
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment - Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma
Phase 2RecruitingMayo Clinic2202023-08-232026-04-20
Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer
Biopsy Procedure, Biospecimen Collection, Cabozantinib S-malate - Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma
Phase 2Active not recruitingNational Cancer Institute (NCI)822018-04-162026-09-09

Narrower conditions

Endometrial Neoplasms (2)  ·  Carcinosarcoma (1)  ·  Multiple Myeloma (1)  ·  Myelodysplastic Syndromes (1)

Broader conditions

Neoplasms (3)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Cardiovascular Diseases (1)

Interventions

Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  Biopsy (1)  ·  Everolimus (1)  ·  Home Care Services (1)  ·  House Calls (1)  ·  Nivolumab (1)  ·  RAD1901 (1)  ·  cabozantinib (1)  ·  elacestrant (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (3)  ·  Canada (1)

Top investigators

Jordyn Silverstein, MD (1)  ·  Roxana S. Dronca, MD (1)  ·  Stephanie Lheureux (1)

Results publications

PMID 35288469

NIH funding

UM1CA186644 (1)